Evaluation of New Screening Technologies
New technologies for breast cancer screening are rapidly diffusing into community practice. Digital breast tomosynthesis is now used in over half of screening centers in the United States, while whole breast ultrasound and abbreviated MRI are emerging tools used in some practices. Artificial intelligence algorithms are also becoming commercially available to assist radiologists in mammography interpretation. While many of these technologies have been evaluated in small controlled trials, the performance of these imaging tools in community practice settings in women with diverse risk characteristics is currently unclear.
With the Breast Cancer Surveillance Consortium, we are seeking to:
- Evaluate the performance of advanced imaging technologies
- Determine patient subgroups for whom advanced imaging technologies are most appropriate